Business

RavenQuest’s George Robinson Appointed Acting President & CEO of Bonify

RavenQuest’s George Robinson Appointed Acting President & CEO of Bonify.

articleRavenquest Biomed IncJanuary 16, 20195/company/ravenquest-biomed-inc/news/ravenquests-george-robinson-appointed-acting-president-and-ceo-of-bonify
RavenQuest’s George Robinson Appointed Acting President & CEO of Bonify

About this update from Ravenquest Biomed Inc

[{"type":"text","content":"\nVANCOUVER, British Columbia, Jan. 16, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE: RQB, OTCQB: RVVQF, Frankfurt: 1IT) announces George Robinson, CEO, has been named interim President & CEO of Bonify Medical Cannabis (BMC), Ltd. (“Bonify”).\n Bonify Chairman, Jeffery Dyck, stated that “George Robinson’s knowledge and experience is superb when it comes to cannabis production pursuant to Health Canada regulations. In the wake of our recent product recall, Robinson and his team at RavenQuest have been instrumental in preserving Bonify’s licenses to cultivate, process and sell cannabis.” “The appointment of Mr. Robinson as acting President & CEO of Bonify is a natural evolution as our organization takes corrective action to emerge as a stronger, compliant and operationally sound licensee moving forward,” Dyck continued. About RavenQuest BioMed Inc. RavenQuest BioMed Inc. is a diversified publicly traded cannabis company with divisions focused upon cannabis production, management services & consulting and specialized research & development. RavenQuest is a licensed producer with facilities located in Markham, Ontario and Edmonton, Alberta. RavenQuest maintains a research partnership with Montreal’s McGill University focused upon cultivar (strain) recognition, plant stabilization and yield maximization of the cannabis plant. The Company focuses on partnerships with Indigenous communities. On Behalf of the Board of Directors of  RAVENQUEST BIOMED INC. “George Robinson” Chief Executive Officer For further information, please contact: Mathieu McDonald, Corporate Communications – 604-484-1230 Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management. Cautionary Note Regarding Forward-Looking Statements All statements in this press release, other than statements of historical fact, are “forward-looking information” with respect to the Company within the meaning of applicable securities laws, including statements with respect to any future performance of Bon...

More updates from Ravenquest Biomed Inc